SELLAS Life Sciences Group, Inc. , a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.
52W Range
71stpctl
Volume
0.52×avg
Market Cap
2.16BUSD
P/E Ratio
-54.9TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
SELLAS Life Sciences Group, Inc.
SLSNASDAQ·USD·Closed
SELLAS Life Sciences Group, Inc.
SLSNASDAQ·USD·Closed
$11.61
−3.09%
$11.61
−$0.37 (3.09%)
52W Range
71stpctl
Volume
0.52×avg
Mkt Cap
2.16BUSD
P/E
-54.9TTM
Div Yield
–ann
SLS: SELLAS Life Sciences Group, Inc. Stock Analysis | finqOS
